Highlights of the Precision in Clinical Trials Summit at the Hilton Boston Park Plaza May 2024

Highlights & Glimpse of the PCT and PMD Summits at the Revere Hotel Boston Common May 1st-2nd, 2023

Highlights & Glimpse of the PCT and PMD Summits at the Revere Hotel Boston Common May 1st-2nd, 2023

Highlights & Glimpse from PCT & PDDP Summit Amsterdam April 3rd-4th, 2023

Highlights & Glimpse from PCT and PDDP Summit Amsterdam April 3rd-4th, 2023

Highlights of the Precision in Clinical Trials / Drug Discovery & Preclinical Summit, Frankfurt 2022

Highlights and Glimpse of the Precision in Drug Discovery & Preclinical Summit Boston June 2022

Highlights and Glimpse of the Precision in Clinical Trials & Precision in Medical Devices Summits

Panel: Deep Diving into Drug Discovery in the New Normal using AI & Breakthrough Technology

Leveraging Natural Language Processing in Pharma R&D - Peter Henstock of Pfizer

Acceleration and De Risking of CVD Drug Discovery and Development - Dr Jaya Krishnan

Accelerating Drug Discovery by AI and Repositioning - Dr Kjell Stenberg of Nodes Advisors

Non-Fungible Antibodies - Monique Seymour of Rapid Novor

Data Management Solutions for Collaborative Drug Discovery - Susana Tomasio of CDD

Cancer Cell Growth: Revisiting a Gordian Knot - Dr Hans Ake Fabricius of Cell Receptor

Transforming Clinical Research: Challenges & Opportunities - Dr Mukesh Kumar of Cipla Pharma

Deep Diving into Clinical Outsourcing in the New Era of Decentralized & Remote Clinical Research.

Conducting Clinical Research During a Pandemic - Dinkar Sindhu, CEO of AXIS Clinicals

Predict & Prepare for Pitfalls in Decentralized Clinical Trials - Dr Jamileh Jemison of MindMed

Can Digital Biomarkers transform Drug Development Pathways for Treating Neuroinflammation post COVID

Patient Engagement During COVID-19 And Beyond- Begonya Nafria

Possible Futures of Clinical Trials, Data, COVID-19 and the Patient - Mick Mullane of NIHR

Digital Measurement of health in Clinical Research: Promise, Challenges, and Future- Anzar Abbas

2022 Life Sciences Hybrid Event Series by Precision Evolution Global (PEG)

Machine Learning & Artificial Intelligence - Zeeshan Khan, CEO of Xenon VR

Precision Medicine: The Way Forward- Dr Prasun Mishra, CEO of Agility Pharma

Involving Patients in the Design Process: Embracing a Co-Design Development Process

New Product Innovation: Integrating the Experience Economy into your next Product - Avishek Mishra

Panel Discussion: Accelerating your Medical Device Development using New Tools in the "New Normal"

Conducting Clinical Trials for Software as a Medical Device- Dr Shaheen and Cathleen of Click TX

Creating Tools to Drive solutions: Setting the Stage for Biomarkers in DCT's - Dr Allyson Gage

The Butterfly Effect, Benefits of A User Centric Product Development by Dr Luis Almodovar

Bringing Bio & MedTech to Improve Outcomes in CNS Diseases- Tony DePasqua, CEO of Enclear Therapies

Building a Digital Health Oncology Company to Improve Cancer Patient Outcomes by Dr Kevin Knopf

Engaging Key Medical Device Stakeholders via Compliant and Secure Virtual Technology by Within3

Pandemic Challenges by Vito Levi D'Ancona of Scientific Ventures

"Grandma, when I grow up I'll get old people out of diapers" - Jerrold Shapiro of Floelle Inc.

Non-Dilutive Government Funding: Providing Companies a Means and a Reason to Innovate - Ryan Myers

Accelerating Medical Device Development using a Customer Centric Agile Approach by Subhrangshu Datta

Bringing Innovation to your Medical Device Project with AI & Breakthrough Technology - Panel

State of the Art Visualization, Robotics & 5G for the Surgery Suite of the Future - Ocutrx Vision

Is the EU the best Launch Market for Novel Therapeutic Devices?

Defining Device Objectives Through Analytics - David William, Health Care Consultant with Milliman

Intro of EU MDR & its impact on Future Device Development for the EU Market- Louis-Paul Marin

Device Based Therapeutics for CNS Disease - Marcie Glicksman of Enclear Therapies

Translational Science in Medical Device Development - Dr. Rafael Veraza

A Revolutionary New Technology to Diagnose and Successfully Treat Cancers and Other Diseases.

Challenges Faced by a Start-Up US Based Medical Device Company - Terry Tormey of Xenon VR

Assay Development for a Novel Encapsulated Cell Therapy in Mucopolysaccharidosis type I Mouse Model

The Rational Design of Plant-Inspired Therapeutic Mixtures, Presented By Dr. Andrea Small-Howard

Exploring New Tools for Remote Collaborative Structure-Based Drug Design - Daniel Gruffat of Nanome

Genetic background matters: population-based studies in model organisms for precision medicine

Ocular distribution and efficacy after suprachoroidal injection of AU-011 for ocular melanoma

The Role of CMC in IND Enabling Studies - Dr Paul O'Shea, CSO of Exemplify Biopharma at PDDP Summit

Giving New Life to Old Drugs the 5(O)5b2 route- Dr Elana Gazal

From Chip to Clinic - Integrating Advanced Physics and AI Approaches to Drug Challenging Targets

Engineering Antibody-based Designer Drugs - Dr. Jagath Reddy Junutula

Antibody Protein Sequencing: Advancing and Safeguarding Discovery - Rapid Novor

A quantum revolution in Drug Discovery keynote presentation by Dr Shahar Keinan, CEO of Polaris QB

Cellular target engagement as a new paradigm in Drug Discovery- Elmar Nurmemmedov, PhD